Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-053260

Chief Business Officer sold 6,945 shares at $34.75 ($241,342)

  • Chief Business Officer acquired 6,945 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Parrish Jay Chief Business Officer 2020-10-01 Option exercise +4,630 $1.49 $6,876 226,852 D
Parrish Jay Chief Business Officer 2020-10-01 Option exercise +2,315 $1.58 $3,646 229,167 D
Parrish Jay Chief Business Officer 2020-10-01 Sale −6,945 $34.75 $241,342 222,222 D
Derivatives
Parrish Jay Chief Business Officer 2020-10-01 Option exercise · Stock Option (Right to Buy) −4,630 32,407 D
Parrish Jay Chief Business Officer 2020-10-01 Option exercise · Stock Option (Right to Buy) −2,315 50,926 D
Open-market sales · 6,945 sh · avg $34.75 · $241,342
Loading xslF345X03/doc4.xml…